Sign in to view content

Best Corrected Visual Acuity (BCVA) and Central Macular Thickness (MAT) Outcomes After Fluocinolone Acetonide Intravitreal Implant Injection

Dana M. Deupree, MD

Video
Published 2018

Related

Brolucizumab: Will it Make a Differance
Andrew P. Schachat, MD
Updates from the Field
2018
Phase 2a Study of CU06-1004, an Oral Endothelial Dysfunction Blocker for the Treatment of Diabetic Macular Edema
Victor Hugo Gonzalez, MD
Updates from the Field
2024
Founders' Award, Playing Your Part in Drug Development, Wiley Chambers, MD
Wiley Chambers, MD
Annual Meeting Talks
2018

Category: Diabetic Retinopathy

See more